BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lo AK, Dawson CW, Lung HL, Wong KL, Young LS. The Therapeutic Potential of Targeting BARF1 in EBV-Associated Malignancies. Cancers (Basel) 2020;12:E1940. [PMID: 32708965 DOI: 10.3390/cancers12071940] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Wyżewski Z, Mielcarska MB, Gregorczyk-zboroch KP, Myszka A. Virus-Mediated Inhibition of Apoptosis in the Context of EBV-Associated Diseases: Molecular Mechanisms and Therapeutic Perspectives. IJMS 2022;23:7265. [DOI: 10.3390/ijms23137265] [Reference Citation Analysis]
2 Han S, Tay JK, Loh CJL, Chu AJM, Yeong JPS, Lim CM, Toh HC. Epstein–Barr Virus Epithelial Cancers—A Comprehensive Understanding to Drive Novel Therapies. Front Immunol 2021;12:734293. [DOI: 10.3389/fimmu.2021.734293] [Reference Citation Analysis]
3 Blanco R, Aguayo F. Role of BamHI-A Rightward Frame 1 in Epstein-Barr Virus-Associated Epithelial Malignancies. Biology (Basel) 2020;9:E461. [PMID: 33322292 DOI: 10.3390/biology9120461] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
4 Grywalska E, Smarz-Widelska I, Korona-Głowniak I, Mertowski S, Gosik K, Hymos A, Ludian J, Niedźwiedzka-Rystwej P, Roliński J, Załuska W. PD-1 and PD-L1 Expression on Circulating Lymphocytes as a Marker of Epstein-Barr Virus Reactivation-Associated Proliferative Glomerulonephritis. Int J Mol Sci 2020;21:E8001. [PMID: 33121190 DOI: 10.3390/ijms21218001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]